 Kura Oncology, Inc. KURA, a clinical-stage biopharmaceutical company focused on the development of precision medicines for the treatment of cancer, today announced that it will report first quarter 2020 financial results after the close of U.S. financial markets on Monday, May 4, 2020. Kuras management will host a webcast and conference call at 4:30 p.m. ET 1:30 p.m. PT that day to discuss the financial results and provide a corporate update. The live call may be accessed by dialing 877-516-3514 for domestic callers and 281-973-6129 for international callers and entering the conference code: 2085246. 